Zurich Insurance Group has disclosed a 1.47% holding in Beazley, following the specialty insurer's rejection of its $10.2bn takeover offer. The move comes as Zurich simultaneously advances plans to establish its first syndicate at Lloyd's of London.
NEW DELHI, Feb 3 (Reuters) - Indian markets surged on relief after U.S. President Donald Trump announced a deal to slash tariffs on Indian imports, though the absence of formal documentation and detailed terms left analysts and officials parsing social media posts for substance.
Cboe Global Markets is developing a new, regulated options product featuring a simplified 'all-or-none' payout structure, targeting retail investors drawn to event-style trading. The move comes as U.S. regulators work to define rules for prediction markets and event contracts.
The recent Symposium on International Automotive Technology indicates India's electric vehicle market is maturing, with future launches focusing on engineering discipline, safety compliance, and platform-based scalability over rapid, incentive-driven rollouts.
The professional services firm elevates seven senior professionals to partner across key advisory divisions, a strategic move aligned with its ambitious plan to add 160 partners within two years.
AstraZeneca has entered a strategic collaboration with China's CSPC Pharmaceutical Group to co-develop and commercialize a portfolio of next-generation therapies for obesity and type 2 diabetes, significantly expanding its weight management pipeline.
Evercore ISI has upgraded Cisco Systems (CSCO) to Outperform, raising its price target to $100. The firm cites a confluence of AI momentum, a critical campus refresh cycle, and margin expansion as key drivers for sustained growth.
The aerospace and defense giant reported strong quarterly results, with sales rising 12% year-over-year. Analysts have responded with revised price targets, citing robust performance across all business segments.
As AbbVie navigates a pivotal year for its key drugs and pipeline, Wall Street analysts are offering mixed signals. While Citi adopts a cautious stance, Berenberg raises its price target, highlighting the contrasting perspectives on the pharmaceutical giant's future.
Wall Street analysts offer mixed signals on Procter & Gamble (NYSE: PG), with recent rating changes highlighting concerns over subdued growth prospects despite its reputation as a defensive staple.
Bank of America has increased its price target for healthcare giant Johnson & Johnson to $227, highlighting its defensive investment profile and growth in MedTech, while downplaying the financial impact of ongoing talc litigation.
Walmart Inc. (WMT) is making a significant push into the health and wellness sector with major investments in pharmacy staffing and services, coinciding with a bullish price target upgrade from UBS. The retail giant's strategic moves come as competition in the pharmacy delivery space intensifies.
Pharmaceutical giant Eli Lilly announces a major investment in a new Lehigh Valley manufacturing site, set to create hundreds of jobs and bolster U.S. production capacity for its in-demand injectable therapies, including weight-loss drugs.
Alibaba's logistics arm, Cainiao, is set to acquire a stake in robovan developer Zelostech, creating a combined entity valued at approximately $2 billion. The strategic move, aimed at bolstering its autonomous freight capabilities, comes as China Merchants Securities reiterates a Buy rating on Alibaba with a HK$194 price target.
Following a robust fiscal fourth-quarter earnings report, Mastercard saw several Wall Street firms raise their price targets, highlighting resilient consumer spending and a key partnership renewal with Capital One as drivers for continued growth.
Financial services giant Macquarie has reiterated its 'Buy' rating on Visa Inc., maintaining a $410 price target following the payment network's robust fiscal first-quarter results, which showcased double-digit growth in revenue and net income.
China's leading automaker BYD reported a sharp 30% year-on-year drop in global sales for January 2026, triggering an 18% plunge in its Hong Kong-listed shares and raising concerns over a sustained slowdown in both domestic and international electric vehicle markets.
A fresh release of court documents related to Jeffrey Epstein has cast a shadow over cryptocurrency's early days, revealing previously undisclosed financial connections to key figures and companies. As the market grapples with volatility, the disclosures prompt a renewed examination of the industry's complex origins.
While rivals like AMD and Broadcom chip away at the edges, Nvidia's most pressing challenge comes from its own biggest customers—tech giants now building their own AI chips.
Facing intensifying competition and declining electric vehicle deliveries, Tesla is making a high-stakes strategic shift, discontinuing key models to double down on its autonomous Cybercab and Optimus humanoid robot.
